Showing the single result
Lupus is a complex autoimmune disorder where the body mistakenly attacks its tissues. This phase 1 clinical trial aims to assess the safety, dosage, and side effects of a novel treatment for SLE in a controlled group, paving the way for effective, targeted therapies.Read more
Criteria & Qualifications: • More than 18 years.
Compensation: Contact us for more information